USD10
KPTI Shares
About Karyopharm TherapeuticsKaryopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
USD10
KPTI Shares
About Karyopharm TherapeuticsKaryopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Stats
TRADING WINDOW
Open
CLOSES AT
9:00 PM UTC
MARKET CAP
$2.38M
OPEN PRICE
$0.081
LOW (1Y)
$0.082
HIGH (1Y)
$10.99
LOW (24H)
$0.081
HIGH (24H)
$0.1268
VOLUME (24H)
$17.32M
88.57%
Price history
Time | Price | Change |
|---|---|---|
Today | $0.081 | |
1 Day | $0.0912 | |
1 Week | $0.5676 | |
1 Month | $0.8022 | |
1 Year | $5.36 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.